GlassScriptPhysician profile
Rafat Abbasi
NPI 1114004496
$2,660.92
in general payments reported to CMS, 2019-2025
10 companies · $403 in 2025
The $403 reported for 2025 was more than what 75% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,356 · 2020: $64.74 · 2021: $108 · 2022: $131 · 2023: $353 · 2024: $246 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,002.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,001.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $1,820.60 | 2019-2025 | Menopur |
| Abbvie INC. | $272.79 | 2019-2022 | |
| Emd Serono, INC. | $200.72 | 2019-2023 | |
| Aerin Medical INC. | $143.84 | 2025 | |
| Merck Sharp & Dohme LLC | $79.24 | 2019-2020 | |
| Coopersurgical, INC. | $44.10 | 2023 | Stripper, Endosee |
| Vitrolife INC. | $39.66 | 2024 | |
| Alfasigma USA, INC. | $32.82 | 2021 | |
| Organon LLC | $14.39 | 2021 | |
| Hologic Sales and Service, LLC | $12.76 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafat Abbasi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.